Gehrie E A, Roubinian N H, Chowdhury D, Brambilla D J, Murphy E L, Gottschall J L, Wu Y, Ness P M, Strauss R G, Hendrickson J E
Johns Hopkins School of Medicine, Baltimore, MD, USA.
University of California, San Francisco, CA, USA.
Vox Sang. 2018 Feb;113(2):160-169. doi: 10.1111/vox.12621. Epub 2017 Dec 25.
Many hospitals require transfusions to be discontinued when vital signs stray from predetermined ranges, regardless of clinical symptoms. Variations in vital signs may be unrelated to transfusion, however, and needlessly stopping a transfusion may delay medical care while increasing donor exposures and healthcare costs. We hypothesized that a detailed study of vital sign changes associated with transfusion of blood product by component, including those associated with potential reactions (complicated) and those deemed to be uncomplicated, would establish a useful framework of reference for treating clinicians and transfusion services alike.
A retrospective electronic record review of transfusion service and transfusion recipient data was completed on 3852 inpatient transfusion episodes over a 6-month period at four academic tertiary care hospitals across the United States. Vital signs pre- and post-transfusion were recorded by trained clinical research nurses. Serious reactions were adjudicated by a panel of transfusion medicine experts.
In both uncomplicated transfusions (n = 3765) and those including an adverse reaction (n = 87), vital sign fluctuations were generally modest. Compared to uncomplicated transfusions, transfusions complicated by febrile reactions were associated with higher pretransfusion temperature and higher pretransfusion pulse rates. Episodes of transfusion circulatory overload were associated with higher pretransfusion respiration rates compared to uncomplicated transfusions.
Most transfusions are associated with only modest changes in vital signs. Pretransfusion vital signs may be an important yet previously understudied predictor of vital sign changes during transfusion. The optimal role of vital sign assessment during blood transfusion deserves further study.
许多医院要求,一旦生命体征偏离预定范围,无论临床症状如何,均应停止输血。然而,生命体征的变化可能与输血无关,不必要地停止输血可能会延误医疗护理,同时增加供体暴露和医疗成本。我们假设,对按成分输血的血液制品相关生命体征变化进行详细研究,包括与潜在反应(复杂反应)和被视为非复杂反应相关的变化,将为临床治疗医生和输血服务机构建立一个有用的参考框架。
在美国四家学术性三级护理医院,对6个月内3852例住院输血事件的输血服务和输血受者数据进行了回顾性电子记录审查。输血前后的生命体征由训练有素的临床研究护士记录。严重反应由输血医学专家小组判定。
在非复杂输血(n = 3765)和包括不良反应的输血(n = 87)中,生命体征波动通常较小。与非复杂输血相比,伴有发热反应的输血与输血前较高的体温和较高的脉搏率相关。与非复杂输血相比,输血循环超负荷事件与输血前较高的呼吸频率相关。
大多数输血仅与生命体征的适度变化相关。输血前生命体征可能是输血期间生命体征变化的一个重要但此前未被充分研究的预测指标。输血期间生命体征评估的最佳作用值得进一步研究。